Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells zum Wirkstoff Aflibercept FER (ATC-Code nach WHO: S01LA05; ausgenommen 114,3 mg/ml)
openAOK PLUS - Die Gesundheitskasse für Sachsen und Thüringen · DE256878834
Value
unstated
Published
11 Nov 2026
Deadline
31 Dec 2027, 22:58 GMT
Type
opportunity · framework
33600000 · Medical equipment, pharmaceuticals & personal careDED21
Description
Siehe Kurzbeschreibung
Key facts
- Procedure
- open
- Framework agreement
- Yes — a framework or dynamic purchasing system, not a single contract
- Contact
- vergabestelle@plus.aok.de
- Contract period
- 3 Dec 2026 → 31 Dec 2027
- Bids opened
- 31 Dec 2027, 22:59 GMT
- Regime
- publicSector
- Category
- supplies
What a subscription adds to this notice
- The documents — every attachment, with its text extracted and searchable
- Qualification — the notice scored against your company profile
- Tracking and alerts — a pipeline for your bids, and the matching notices by email
- Calendar export — the deadline as a calendar file
- The API and MCP — the same record in your own tools and your AI assistant
Provenance
- Source
- ted-eu
- Notice id
- 785160-2026
- First seen
- 11 Nov 2026
- Last updated
- 11 Nov 2026
Licence EU reuse — Commission Decision 2011/833/EU ↗
Source: TED — Tenders Electronic Daily (ted.europa.eu), © European Union, reused under Commission Decision 2011/833/EU.
View at source ↗
GET /api/v1/tenders/094019db-f10c-4147-8157-e1314c1a9d7eThe source notice is authoritative — verify deadlines and documents there before bidding.